Importing Radiopharmaceuticals: Import Compliance for Research

The future of targeted medicine depends on the rapid execution of clinical trials for radiopharmaceuticals. Delivering trial-critical radioisotopes leaves zero margin for error, requiring seamless alignment between clinical sites, specialized logistics, and complex radiation control frameworks before physical decay compromises treatment viability.

Challenges Importing Radiopharmaceuticals

Importing radiopharmaceuticals demands flawless execution and rigorous alignment across complex regulatory frameworks. Even minor documentation oversights can trigger severe customs delays. Therefore,  navigating the import process requires strict compliance and precise coordination to ensure these high-risk, time-critical goods clear border controls without disruption.

• Radiation Safety Documentation: Shipments require specialized paperwork detailing specific activity, radioisotope authorization, and transport index data.
• Regulatory Dual Tracks: Consignments must navigate simultaneous import approvals from both national health agencies and atomic energy control boards.
• Time Sensitivity: Customs delays can cause the product to decay, rendering it unusable for clinical trial participants.

Partnering with an experienced Importer of Record (IOR) eliminates these border bottlenecks by guaranteeing full regulatory alignment before each shipment. Given the narrow decay windows of importing radiopharmaceuticals, a reliable IOR partner mitigates million-dollar delay risks and ensures life-saving trial products reach patients safely and on time.

The Regulatory Impact of Importing Radiopharmaceuticals on Logistics

Due to their radioactive nature, these items are classified simultaneously as Investigational Medicinal Products and Dangerous Goods. Every major global market, including the European Union, Singapore, South Korea, Turkey, Israel, Argentina, and Brazil, mandates two parallel licensing tracks for customs clearance.

What Are Dangerous Goods?

Dangerous goods within the clinical trial scene are classified as goods that may cause harm to human health, safety and the environment surrounding them. These goods are required to be stored according to strict protocols in order to ensure they do not become hazardous. If the incorrect protocols are followed when dealing with dangerous goods such as importing radiopharmaceuticals, this may have a major impact on all surrounding people and their environment. Furthermore, these risks can lead to illnesses or diseases, fatalities such as death, property and environmental destruction. It is therefore important to ensure that you have a professional IOR service in place who understands the danger associated with radiopharmaceuticals and what processes are needed to be put in place in order for the goods to clear customs and be delivered to their end users without causing any disruptions along the way.

Case Study Analysis on Importing Radiopharmaceuticals

TecEx Medical is dedicated to assisting sponsors and Contract Research Organizations (CROs) with complex imports of radiopharmaceuticals. A recent order supported a Phase 2, Randomized, Open-Label, Multicenter Study evaluating the safety and efficacy of FPI-2265 in patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC).

These time-sensitive shipments moved from Canada to South Korea. Given the severe timeline pressures associated with active radioisotopes, ensuring pre-cleared customs protocols was paramount. Working closely with our in-country team, TecEx Medical successfully managed the clearance and delivery of these by importing the radiopharmaceuticals proactively, ensuring full regulatory compliance and optimal radioactivity prior to administration.

How a Specialist Importer of Record Assists Importing Radiopharmaceuticals

TecEx Medical provides end-to-end support, from initial commercial alignment through specialized customs clearance to final destination delivery. The team prepares customized, country-specific documentation packages for every shipment, managing radioisotope import licenses, pre-notifications, live shipment tracking, and ongoing regulatory reviews.

TecEx Medical supports radiopharmaceutical import requirements across expanding global territories, outlined by operational readiness:

Types of Radiopharmaceuticals

• Diagnostic Radiopharmaceuticals: Diagnostic tracers, including Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT) agents, map disease locations in the body. They feature rapid physical decay rates, often expiring within minutes to hours.
• Therapeutic Radiopharmaceuticals: Designed to treat target tissues, these products carry longer physical half-lives that generally decay over several days. Clinical trial shipments often consist of ready-to-administer therapeutic treatments produced by central manufacturing facilities.
• Theranostics: This dual-action approach couples a diagnostic isotope, which visualizes the disease target and confirms patient eligibility, with a therapeutic isotope utilizing the exact same targeting molecule.

Defining Radiopharmaceuticals

Radiopharmaceuticals are specialized medicinal products that bind a radioactive radionuclide to a targeting vector, such as a small molecule, peptide, or monoclonal antibody. This vector carries the isotope directly to targeted cells, most commonly within a tumor microenvironment.

In clinical research, the focus is increasingly on therapeutic radioligand therapy. Unlike diagnostic tracers used purely for imaging, therapeutic radiopharmaceutical products emit targeted radiation, such as alpha or beta particles, to destroy disease cells.

When importing radiopharmaceutical shipments, timing is critical. The active product undergoes physical decay from the exact moment of manufacturing according to a fixed schedule, often requiring patient administration within a precise window of hours.

Successfully importing radiopharmaceuticals requires a highly specialized approach to international trade compliance, cold-chain logistics, and radiation control. When managing the physical decay of therapeutic isotopes, working with an experienced Importer of Record ensures regulatory alignment, minimizes customs friction, and protects the integrity of trial-critical supplies.